+1-888-308-5802     
News Contact Us

Eli Lilly to spin off its Greenfield-based animal health arm, Elanco

Author : Ojaswita Kutepatil | Published Date : 2018-07-27 

Eli Lilly & Co., a leading pharmaceutical company has reportedly announced its plan to spin off its Greenfield-based animal health unit - Elanco, after going through a month-long review regarding its business in animal healthcare and agriculture. The company is expecting to complete the spinoff by the second half of this year, while the initial offering is anticipated to go public over the coming weeks.

Reportedly, the spinoff is considered to be one of the biggest strategic decisions taken by Dave Ricks, the Chief Executive Officer of Eli Lilly. The CEO revealed in a company statement that the decision for the spinoff had been taken mainly in favor of their shareholders.

For the record, Elanco sells medication for pets and livestock and had USD 3.09 billion in revenue last year. The company has scaled rapidly through its acquisition strategies, and have taken almost 10 companies since 2007 which includes the buyout of Novartis AG’s animal-health unit for USD 5.4 billion in 2015. A year after, the unit opened a 48,000-sq foot research facility next to its Greenfield Indiana, H.Q. to develop vaccines for livestock and pets.

According to the Eli Lilly, its per share earning has risen from $1.30 average in the second quarter to $1.50. The company has also raised its full-year adjusted earnings forecast from a $5.10 to $5.20 in June to $5.40 to $5.50 a share.

As per an official statement, the pharma company plans to offer less than 20% of Elanco stock in an initial public offering. The firm later plans to sell the remaining shares through a tax-efficient transaction.

Further, Lilly stated that the company doesn’t plan to increase the price of any drug for the whole year and will remain focused on gaining profit through volume and not through higher drug prices.

About Author

Ojaswita Kutepatil

Ojaswita Kutepatil

Equipped with an ardent interest in writing, Ojaswita Kutepatil, a content developer by profession, presently writes articles for fractovia.org and a couple of other portals. When she isn’t harnessing the power of the pen, she loves to pursue her hobbies of cooking, reading, and crafting, to name a few. She can be contacted at- [email protected] | https://twitter.com/ojaswita_k

Related News

Go-Jek secures additional $100M in funds from Astra International

Published Date: 2019-03-05         Author: Ojaswita Kutepatil

Go-Jek, the Indonesian ride-hailing & logistics startup, is currently in the news for raising another $100 million in its ongoing Series F investment round, with the help of which the company aims to secure at least $2 billion in the long run. As per trusted sources, the latest cash influx co... Read More

Adaptive3D secures financing from latest Series A investment round

Published Date: 2019-02-06         Author: Ojaswita Kutepatil

Applied Ventures LLC and DSM Venturing led the Series A investment round.   The investment round also saw participation from Chemence & current investors that were led by late Margaret McDermott & Mary McDermott Cook. Adaptive3D Technologies (Adaptive3D), an American additiv... Read More

Uber Eats to pilot Coles’ ready-to-eat meals in a new partnership deal

Published Date: 2019-01-29         Author: Ojaswita Kutepatil

The supermarket giant Coles has teamed up with Uber Eats to test-launch meal delivery services across Australia Uber Eats, an American online food delivery platform, and Australian supermarket chain Coles, have reportedly signed a partnership agreement for meal delivery to customers. Under the pa... Read More

© 2019 Fractovia. All Rights Reserved